loading page

Impact of corticosteroid use in COVID-19 infection: A rapid clinical review
  • +4
  • Zeinab Mohseni Afshar,
  • Mohammad Barary,
  • Soheil Ebrahimpour,
  • Amirhossein Hasanpour,
  • Alireza Janbakhsh,
  • Babak Sayad,
  • Arefeh Babazadeh
Zeinab Mohseni Afshar
Kermanshah University of Medical Sciences
Author Profile
Mohammad Barary
Babol University of Medical Science
Author Profile
Soheil Ebrahimpour
Babol University of Medical Science
Author Profile
Amirhossein Hasanpour
Babol University of Medical Science
Author Profile
Alireza Janbakhsh
Kermanshah University of Medical Sciences
Author Profile
Babak Sayad
Kermanshah University of Medical Sciences
Author Profile
Arefeh Babazadeh
Babol University of Medical Science

Corresponding Author:drbabazadeh.a@yahoo.com

Author Profile

Abstract

Coronavirus disease 2019 (COVID-19) is caused by infecting with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was recognized in late December 2019 in Wuhan, China. As the infection spread and rapidly becomes a global pandemic, effective therapy is urgently needed against the new coronavirus due to the increased morbidity and mortality rates. Based on this aspect, several therapeutic options have been explored, one of which is corticosteroids. Though the application of corticosteroids in treating COVID-19 remains controversial, this review aimed to evaluate and describe the effectiveness and safety of corticosteroids in the management of COVID-19.